NCT06781424|Recruiting
Loading search results
Sponsor study identifier
observational
10,000
1 country
1
Study Start
January 13, 2025
Actual (reported)Primary Completion
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 13, 2025
Actual (reported)January 13, 2025
Actual (reported)January 17, 2025
Actual (reported)January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Receipt of donated biospecimen for aerospace research
Donated biospecimens from participants will aid in the improvement of medical aerospace research. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
50 years
Participants who have who travel (such as space travel) or live in extreme environments (such as Antarctica).
Participants who have been referred adult family members (such as siblings and spouses) of primary enrollees.
Participants from the general public to serve as matching controls.
The target population comprises of persons from many countries. Therefore, enrollees can be from other countries. However, biospecimen collection will occur in the USA.
University of Central Florida
Orlando, Florida, 32827, United States
First Submitted
January 13, 2025
First Posted
January 17, 2025
Study Start
January 13, 2025
Actual (reported)Primary Completion
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Contact the study team to confirm eligibility.
Study Completion
January 13, 2075
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 26, 2025
Record last verified: 2025-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: